HemOnc Today New York

Healio.com brings you the highlights from HemOnc Today New York. Refer back to this page often to read the latest news, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting News

Experts debate CAR T-cell therapy vs. transplant for relapsed diffuse large B-cell lymphoma

March 23, 2019
NEW YORK — Chimeric antigen receptor T-cell therapy confers better outcomes than autologous stem cell transplant to some patients with relapsed…

CAR T-cell therapy changing the landscape of lymphoma treatment

March 23, 2019
NEW YORK — Chimeric antigen receptor T cell therapies could be the breakthrough hematologists have sought to effectively treat certain patients…
Meeting News

Future ‘very bright’ in acute myeloid leukemia

March 23, 2019
NEW YORK — Treatment options for acute myeloid leukemia have evolved rapidly, but the expanded armamentarium has created a new set of…
Meeting News

First-line treatment for metastatic renal cell carcinoma evolving, but biomarkers still lacking

March 22, 2019
NEW YORK — First-line treatment of patients with metastatic renal cell carcinoma has evolved considerably in the past 18 months with FDA…
Meeting News

Rising PSA contributes to lack of clarity in nonmetastatic prostate cancer

March 22, 2019
NEW YORK — PSA is an “imperfect biomarker” that should inform prostate cancer treatment but not dictate it, according to a…

Molecular therapy for lung cancer has not evolved quickly enough

March 22, 2019
Molecular therapy for the treatment of lung cancer has not evolved enough to adequately extend survival of patients, according to a presenter at…

Immunotherapy likely to become standard for recurrent/metastatic head and neck cancers

March 22, 2019
The standard treatment for patients with recurrent or metastatic head and neck cancers is expected to change from chemotherapy to immunotherapy based…
Meeting News

Cisplatin superior to cetuximab for locally advanced head and neck cancer

March 22, 2019
NEW YORK — Cisplatin appears to be superior to cetuximab for patients with locally advanced head and neck cancer regardless of HPV status…
Meeting News

Genetic testing can detect melanoma earlier, but tailored approach is required

March 21, 2019
Genetic testing can help increase early detection of melanoma among patients and their family members, according to a presenter at HemOnc Today New…
Meeting News

Standards evolve for adjuvant therapy of melanoma

March 21, 2019
NEW YORK — A strong rationale exists for offering adjuvant therapy to certain patients with melanoma, but several aspects of treatment remain…

Meeting Calendar

HemOnc Today New York Presents - What oncologists need to know: A practical look at advances, challenges and trends

March 21, 2019 - March 23, 2019

Save $25 with priority code: Healio25